JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) Trading Up 0.2% – Time to Buy?

Shares of JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) traded up 0.2% during trading on Tuesday . The stock traded as high as $55.46 and last traded at $55.46. 3,576 shares traded hands during trading, an increase of 246% from the average session volume of 1,033 shares. The stock had previously closed at $55.36.

JPMorgan Healthcare Leaders ETF Stock Up 0.2%

The company has a market cap of $9.43 million, a P/E ratio of 22.43 and a beta of 0.56. The firm has a fifty day moving average price of $57.09 and a 200 day moving average price of $56.67.

Hedge Funds Weigh In On JPMorgan Healthcare Leaders ETF

Several large investors have recently made changes to their positions in the company. Sanctuary Advisors LLC lifted its stake in shares of JPMorgan Healthcare Leaders ETF by 12.7% during the fourth quarter. Sanctuary Advisors LLC now owns 6,359 shares of the company’s stock valued at $368,000 after acquiring an additional 718 shares during the period. Blue Water Asset Management acquired a new stake in shares of JPMorgan Healthcare Leaders ETF during the fourth quarter worth about $237,000. Ignite Planners LLC grew its holdings in shares of JPMorgan Healthcare Leaders ETF by 136.8% during the fourth quarter. Ignite Planners LLC now owns 9,460 shares of the company’s stock worth $553,000 after buying an additional 5,465 shares in the last quarter. Krilogy Financial LLC bought a new position in shares of JPMorgan Healthcare Leaders ETF during the third quarter worth about $325,000. Finally, Jane Street Group LLC bought a new position in shares of JPMorgan Healthcare Leaders ETF during the second quarter worth about $1,166,000.

About JPMorgan Healthcare Leaders ETF

The JPMorgan Healthcare Leaders ETF Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation. JDOC was launched on Nov 1, 2023 and is issued by JPMorgan Chase.